- Home
- AVTX vs NRDS Comparison
AVTX vs NRDS Comparison
Compare AVTX & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | NRDS |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 640.8M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AVTX | NRDS |
|---|---|---|
| Price | $7.48 | $11.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $44.08 | $11.50 |
| AVG Volume (30 Days) | ★ 1.0M | 637.8K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | 68.42 |
| EPS | N/A | ★ 0.37 |
| Revenue | $27,813,137.00 | ★ $836,600,000.00 |
| Revenue This Year | N/A | $9.10 |
| Revenue Next Year | N/A | $6.02 |
| P/E Ratio | ★ N/A | $28.22 |
| Revenue Growth | ★ 2312.27 | 21.67 |
| 52 Week Low | $11.21 | $7.33 |
| 52 Week High | $24.27 | $16.24 |
Technical Indicators
Market Signals| Indicator | AVTX | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 18.40 | 76.14 |
| Support Level | N/A | $9.45 |
| Resistance Level | $20.54 | $11.38 |
| Average True Range (ATR) | 0.97 | 0.37 |
| MACD | -0.26 | 0.19 |
| Stochastic Oscillator | 8.65 | 99.05 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.